Skip to main content
OpenTrials

Clinical trial condition

Polyradiculoneuropathy

Explore clinical trials studying Polyradiculoneuropathy. Study availability and eligibility vary by location and protocol.

166 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Polyradiculoneuropathy trial results

Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

NCT06680037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
Locations
  • TG Therapeutics Investigational Trial Site La Jolla, California, United States
  • TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
  • TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT07540221

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy), +12 more
Locations
  • GC2402 Study Site 104 Rancho Mirage, California, United States
  • GC2402 Study Site 109 Coral Springs, Florida, United States
  • GC2402 Study Site 105 Miami, Florida, United States
  • GC2402 Study Site 103 Port Charlotte, Florida, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

NCT06858579

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Clinical Study Site Birmingham, Alabama, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Scottsdale, Arizona, United States
  • Clinical Study Site Los Angeles, California, United States
View all 192 locations
View Trial Details
Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Healthcare Innovations Institute Inc Coral Springs, Florida, United States
  • Neurology Associates PA Maitland, Florida, United States
  • ALS Center at the University of Miami Miami, Florida, United States
View all 120 locations
View Trial Details
Recruiting

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Alabama Neurology Associates- Site Number : 8400019 Homewood, Alabama, United States
  • Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014 Scottsdale, Arizona, United States
  • Keck School of Medicine of University of Southern California- Site Number : 8400002 Los Angeles, California, United States
  • University of California Irvine Medical Center- Site Number : 8400007 Orange, California, United States
View all 135 locations
View Trial Details
Recruiting

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

NCT06920004

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +14 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Samir Macwan, M.D., Inc. Rancho Mirage, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 89 locations
View Trial Details
Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07032662

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Number - 1612 Tucson, Arizona, United States
  • Site Number - 1618 Carlsbad, California, United States
  • Site Number - 1619 Orange, California, United States
  • Site Number - 1607 Rancho Mirage, California, United States
View all 141 locations
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06752356

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • USF Health - Morsani Center for Advanced Healthcare Tampa, Florida, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Advanced Neurology Epilepsy and Sleep Center/ANESC Research El Paso, Texas, United States
View Trial Details

Related conditions